New Orleans Pulmonary Hypertension Biobank

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLouisiana State University Health Sciences Center in New Orleans

About this trial

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.

Eligibility criteria

Qualifiers

Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR

Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR

Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR

Undergoing outpatient right heart catheterization

Disqualifiers

Age<18

Pregnant

Unable to understand English

Currently incarcerated

Trial design

Treatments tested in this trial

  • No intervention. Biospecimen collection only

Treatment groups

450 Participants
are divided into 3 treatment groups